Abdel Rasheed NO, Ibrahim WW (2022) Telmisartan neuroprotective effects in 3-nitropropionic acid Huntington’s disease model in rats: Cross talk between PPAR-γ and PI3K/Akt/GSK-3β pathway. Life Sci 297:120480. https://doi.org/10.1016/j.lfs.2022.120480
CAS Article PubMed Google Scholar
Avila DS, Colle D, Gubert P, Palma AS, Puntel G, Manarin F, Noremberg S, Nascimento PC, Aschner M, Rocha JB (2010) A possible neuroprotective action of a vinylic telluride against Mn-induced neurotoxicity. Toxicol Sci 115(1):194–201
Behrens MM, Ali SS, Dao DN, Lucero J, Shekhtman G, Quick KL, Dugan LL (2007) Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase. Science 318(5856):1645–1647
Benarroch EE (2017) Nrf2, cellular redox regulation, and neurologic implications. Neurology 88(20):1942–1950
Bouvier E, Brouillard F, Molet J, Claverie D, Cabungcal JH, Cresto N, Doligez N, Rivat C, Do KQ, Bernard C (2017) Nrf2-dependent persistent oxidative stress results in stress-induced vulnerability to depression. Mol Psychiatry 22(12):1701–1713
Brandes MS, Gray NE (2020) NRF2 as a therapeutic target in neurodegenerative diseases. Am Soc Neurochem 12:1759091419899782. https://doi.org/10.1177/1759091419899782
Choi DH, Lee KH, Kim JH, Seo JH, Kim HY, Shin CY, Han JS, Han SH, Kim YS, Lee J (2014) NADPH oxidase 1, a novel molecular source of ROS in hippocampal neuronal death in vascular dementia. Antioxid Redox Signal 21(4):533–50
Culling CFA (2013) Handbook of histopathological and histochemical techniques, 3rd edn. Butterworths, London, UK
Damiano M, Galvan L, Deglon N, Brouillet E (2010) Mitochondria in Huntington’s disease. Biochim Biophys Acta Mol Basis Dis 1802(1):52–61
Duan W, Guo Z, Jiang H, Ware M, Li XJ, Mattson MP (2003) Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice. Proc Natl Acad Sci USA 100(5):2911–2916
Elbaz EM, Senousy MA, El-Tanbouly DM, Sayed RH (2018) Neuroprotective effect of linagliptin against cuprizone-induced demyelination and behavioural dysfunction in mice: a pivotal role of AMPK/SIRT1 and JAK2/STAT3/NF-КB signalling pathway modulation. Toxicol Appl Pharmacol 352:153–161
Ferrer I, Goutan E, Marin C, Rey MJ, Ribalta T (2000) Brain-derived neurotrophic factor in Huntington disease. Brain Res 866(1–2):257–261
Gao HM, Liu B, Hong JS (2003) Critical role for microglial NADPH oxidase in rotenone-induced degeneration of dopaminergic neurons. J Neurosci 23(15):6181–7
Gao Y, Chu SF, Li JP, Zhang Z, Yan JQ, Wen ZL, Xia CY, Mou Z, Wang ZZ, He WB, Guo XF, Wei GN, Chen NH (2015) Protopanaxtriol protects against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington’s disease. Acta Pharmacol Sin 36(3):311–322
Ghosh A, Kanthasamy A, Joseph J, Anantharam V, Srivastava P, Dranka BP, Kalyanaraman B, Kanthasamy AG (2012) Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson’s disease. J Neuro-Inflamm 9(1):1–16
Gonchar OO, Maznychenko AV, Klyuchko OM, Mankovska IM, Butowska K, Borowik A, Piosik J, Sokolowska I (2021) C60 fullerene reduces 3-nitropropionic acid-induced oxidative stress disorders and mitochondrial dysfunction in rats by modulation of p53, Bcl-2 and Nrf2 targeted proteins. Int J Mol Sci 22(11):5444. https://doi.org/10.3390/ijms22115444
CAS Article PubMed PubMed Central Google Scholar
Gopinath K, Prakash D, Sudhandiran G (2011) Neuroprotective effect of naringin, a dietary flavonoid against 3-nitropropionic acid-induced neuronal apoptosis. Neurochem Int 59(7):1066–1073
Gu Z, Cui J, Brown S, Fridman R, Mobashery S, Strongin AY, Lipton SA (2005) A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia. J Neurosci 25(27):6401–6408
Harraz MM, Marden JJ, Zhou W, Zhang Y, Williams A, Sharov VS, Nelson K, Luo M, Paulson H, Schöneich C (2008) SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model. J Clin Invest 118(2):659–670
CAS PubMed PubMed Central Google Scholar
Huang K, Chen C, Hao J, Huang J, Wang S, Liu P, Huang H (2015) Polydatin promotes Nrf2-ARE anti-oxidative pathway through activating Sirt1 to resist AGEs-induced upregulation of fibronetin and transforming growth factor-β1 in rat glomerular messangial cells. Mol Cell Endocrinol 399:178–189
Huang YY, Wang YQ, Gao YM, Liu QZ, Ye FF, Guo B, Wu YC, Xue L (2020) BDNF and its multirole function in neurogenesis, synaptic transmission and neurodegenerative diseases. Nano Life 10(01n02):2040007. https://doi.org/10.1142/s1793984420400073
Ibrahim WW, Ismail HM, Khattab MM, Abdelkader NF (2020) Cognitive enhancing effect of diapocynin in D-galactose-ovariectomy-induced Alzheimer’s-like disease in rats: Role of ERK, GSK-3β, and JNK signaling. Toxicol Appl Pharmacol 398:115028. https://doi.org/10.1016/j.taap.2020.115028
CAS Article PubMed Google Scholar
Illarioshkin SN, Klyushnikov SA, Vigont VA, Seliverstov YA, Kaznacheyeva EV (2018) Molecular pathogenesis in Huntington’s disease. Biochemistry 83(9):1030–1039
Jackman KA, Miller AA, De Silva TM, Crack PJ, Drummond GR, Sobey CG (2009) Reduction of cerebral infarct volume by apocynin requires pretreatment and is absent in Nox2-deficient mice. Br J Pharmacol 156(4):680–688
Joseph LC, Kokkinaki D, Valenti MC, Kim GJ, Barca E, Tomar D, Hoffman NE, Subramanyam P, Colecraft HM, Hirano M (2017) Inhibition of NADPH oxidase 2 (NOX2) prevents sepsis-induced cardiomyopathy by improving calcium handling and mitochondrial function. J Clin Invest Insight 2(17):e94248. https://doi.org/10.1172/jci.insight.94248
Kanegae MLP, Condino-Neto A, Pedroza LA, de Almeida AC, Rehder J, da Fonseca LM, Ximenes VF (2010) Diapocynin versus apocynin as pretranscriptional inhibitors of NADPH oxidase and cytokine production by peripheral blood mononuclear cells. Biochem Biophys Res Commun 393(3):551–554
Kim EJ, Jang M, Lee MJ, Choi JH, Lee SJ, Kim SK, Jang DS, Cho IH (2017) Schisandra chinensis Stem ameliorates 3-nitropropionic acid-induced Striatal Toxicity via activation of the Nrf2 pathway and inhibition of the MAPKs and NF-КB pathways. Front Pharmacol 8:673. https://doi.org/10.3389/fphar.2017.00673
CAS Article PubMed PubMed Central Google Scholar
Li B, Liu J, Gu G, Han X, Zhang Q, Zhang W (2020) Impact of neural stem cell-derived extracellular vesicles on mitochondrial dysfunction, sirtuin 1 level, and synaptic deficits in Alzheimer’s disease. J Neurochem 154(5):502–518
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25(4):402–408
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Luchtefeld R, Luo R, Stine K, Alt ML, Chernovitz PA, Smith RE (2008) Dose formulation and analysis of diapocynin. J Agric Food Chem 56(2):301–306
Lull ME, Levesque S, Surace MJ, Block ML (2011) Chronic apocynin treatment attenuates beta amyloid plaque size and microglial number in hAPP (751) SL mice. PLoS One 6(5):e20153
Maldonado PD, Molina-Jijón E, Villeda-Hernández J, Galván-Arzate S, Santamaria A, Pedraza-Chaverr J (2010) NAD(P)H oxidase contributes to neurotoxicity in an excitotoxic/prooxidant model of Huntington’s disease in rats: protective role of apocynin. J Neurosci Res 88(3):620–629
Memet S (2006) NF-КB functions in the nervous system: from development to disease. Biochem Pharmacol 72(9):1180–1195
Napolitano M, Zei D, Centonze D, Palermo R, Bernardi G, Vacca A, Calabresi P, Gulino A (2008) NF-kB/NOS cross-talk induced by mitochondrial complex II inhibition: implications for Huntington’s disease. Neurosci Lett 434(3):241–246
Pestana RR, Kinjo ER, Hernandes MS, Britto LR (2010) Reactive oxygen species generated by NADPH oxidase are involved in neurodegeneration in the pilocarpine model of temporal lobe epilepsy. Neurosci Lett 484(3):187–191
Putra M, Gage M, Sharma S, Gardner C, Gasser G, Anantharam V, Thippeswamy T (2020) Diapocynin, an NADPH Oxidase Inhibitor, counteracts diisopropylfluorophosphate-induced long-term neurotoxicity in the rat model. Ann N Y Acad Sci 1479(1):75–93
Rahman S, Islam R (2011) Mammalian Sirt1: insights on its biological functions. Cell Commun Signal 9:11. https://doi.org/10.1186/1478-811X-9-11
CAS Article PubMed PubMed Central Google Scholar
Ren Z, He H, Zuo Z, Xu Z, Wei Z, Deng J (2019) The role of different SIRT1-mediated signaling pathways in toxic injury. Cell Mol Biol Lett 24:36. https://doi.org/10.1186/s11658-019-0158-9
Article PubMed PubMed Central Google Scholar
Ross CA, Aylward EH, Wild EJ, Langbehn DR, Long JD, Warner JH, Scahill RI, Leavitt BR, Stout JC, Paulsen JS (2014) Huntington disease: natural history, biomarkers and prospects for therapeutics. Nat Rev Neurol 10(4):204–216
Sayed NH, Fathy N, Kortam MA, Rabie MA, Mohamed AF, Kamel AS (2020) Vildagliptin attenuates Huntington’s disease through activation of GLP-1 receptor/PI3K/Akt/BDNF pathway in 3-nitropropionic acid rat model. Neurotherapeutics 17(1):252–268
留言 (0)